CTRI/2018/01/011135已完成未知
A prospective randomised study comparing the standard weight based technique and a novel technique based on combined width of index, middle and ring fingers for proseal laryngeal mask airway size selection in Indian paediatric patients.
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- A
- 入组人数
- 102
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All paediatric patients undergoing elective surgical procedures of short duration ( < 1-2 hour) like circumcision, open herniotomies, anal dilatation, urethral dilatation, open hernia repair etc., requiring general anaesthesia.
- •(a)Age: 6 months to 10 years
- •(b)Weighing between 5-30 kg
- •(c)American Society of Anesthesiologists Physical Status I and II
- •(d)Parents of children willing to comply with informed written consent
排除标准
- •1.Patients not belonging to above mentioned age and ASA status.
- •2.Patientâ??s / parental refusal to participate.
- •3.Ex-preterm infants.
- •4.Emergency surgeries and patients with history of hiatus hernia.
- •5.Patients with history of obstructive sleep apnoea, asthma, congenital heart disease, obesity, mental retardation.
- •6.Recent history of respiratory tract infection.
- •7.Children requiring rapid sequence induction.
- •8.Children with unstable cervical spine or limited neck mobility.
- •9.Children with cleft palate of any degree.
- •10.Anticipated difficult airway.
- •11.Complete upper airway obstruction.
- •12.Suspected or known abnormalities of the airway.
- •13.Morbid obesity.
研究者
相似试验
进行中（未招募）
1 期
A prospective randomised study to compare a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 25 mg with a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg in patients with uncontrolled hypertension who fail to respond adequately to treatment with a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg.EUCTR2005-002442-19-FIBoehringer Ingelheim Finland Ky1,600
进行中（未招募）
1 期
A prospective randomised study to compare a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 25 mg with a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg in patients with uncontrolled hypertension who fail to respond adequately to treatment with a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg.EUCTR2005-002442-19-ESBoehringer Ingelheim España, S.A.1,600
进行中（未招募）
1 期
A prospective randomised study to compare a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 25 mg with a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg in patients with uncontrolled hypertension who fail to respond adequately to treatment with a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg.EUCTR2005-002442-19-DKBoehringer Ingelheim Ireland Ltd.1,600
进行中（未招募）
不适用
A prospective randomised study to compare a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 25 mg with a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg in patients with uncontrolled hypertension who fail to respond adequately to treatment with a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg.essential hypertensionEUCTR2005-002442-19-DEBoehringer Ingelheim Pharma GmbH & Co. KG1,600
进行中（未招募）
1 期
A prospective randomised study to compare a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 25 mg with a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg in patients with uncontrolled hypertension who fail to respond adequately to treatment with a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg.essential hypertensionEUCTR2005-002442-19-IEBoehringer Ingelheim Ltd.1,600